Mosaic Clinical Technologies Announces FDA Breakthrough Device Designation for Cognita’s Generative AI Model for Radiology

Written By Christopher Hardy

Mosaic Clinical Technologies Announces FDA Breakthrough Device Designation for Cognita’s Generative AI Model for Radiology

Christopher Hardy
Previous

Mosaic Clinical Technologies Launches Mosaic Reporting, an AI-Native Reporting Platform Built for Radiology Workflows
Next

UnityAI Raises $8.5M to Expand an Autonomous AI Workforce for Healthcare Operations